GitLab is the DevOps platform that helps organizations to maximize the overall return on software development.

GitLab Inc. is the open core company that provides GitLab, The DevOps Platform, that empowers organizations to maximize the overall return on software development by delivering software faster and efficiently while strengthening security and compliance. GitLab‚Äôs single application is easier to use, leads to faster cycle time and allows visibility throughout and control over all stages of the DevOps lifecycle. With GitLab, every team in your organization can collaboratively plan, build, secure, and deploy software to drive business outcomes faster with complete transparency, consistency and traceability. Built on Open Source, GitLab works alongside its growing community, which is composed of thousands of developers and millions of users, to continuously deliver new DevOps innovations. GitLab has an estimated 30 million+ registered users (both Paid and Free) from startups to global enterprises, including Ticketmaster, Jaguar Land Rover, Nasdaq, Dish Network, and Comcast trust GitLab to deliver great software faster. All-remote since 2015, GitLab has more than 1,350 team members in over 65 countries.

GitLab

Senior Director, Accounting

Senior Director, Revenue Accounting

Fastly helps digital businesses keep pace with their customer expectations by delivering secure and online experiences.

Fastly helps the world‚Äôs most popular digital businesses keep pace with their customer expectations by delivering fast, secure, and scalable online experiences. Businesses trust the Fastly edge cloud platform to accelerate the pace of technical innovation, mitigate evolving threats, and scale on demand. The company's edge cloud platform enables the best of the web to thrive and helps to deliver better online experiences. It was founded in 2011 and headquartered in San Francisco, California.

Fastly

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company‚Äôs cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte‚Äôs proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

Vaxcyte

Sr. Director, Technical Accounting & SEC Reporting

Metropolis is an AI and computer vision start-up built to modernize parking and empower the future of mobility.

Metropolis is an AI and computer vision start-up built to modernize parking and empower the future of mobility. It was founded in 2017 and is based in Los Angeles, California.

Metropolis

Senior Director, Technical Accounting and Reporting

Artera is a SaaS digital health leader in patient communications and 2021 and 2022 Best in KLAS winner in Patient Outreach.

Artera (formerly WELL Health¬Æ) is the patient communication platform that delivers happier staff, healthier patients, and more profitable organizations. We enable two-way conversations between patients and their healthcare teams through secure, multilingual messaging across multiple channels ‚Äì including text, email, and telephone. By unifying disjointed touchpoints into a single, intuitive channel, Artera fuels connected patient experiences and empowers organizations to deliver the best customer service imaginable.Partnering with over 500 healthcare organizations to connect  with 40 million patients annually, Artera is dedicated to fostering deeper connections between patients and their healthcare teams and, ultimately, redefining the patient experience to one that is both personalized and frictionless.

Artera (formerly WELL Health)

Leia is a nanotechnology company that offers 3D lightfield products and software applications.

Leia is an experience platform that provides 3D Lightfield products and software applications that push the boundaries of what can be created and displayed on a screen. Leading brands in the automotive, education, gaming, hospitality, medical, and retail industries are adopting Lightfield as the de facto medium for connecting with their customers and redefining their markets. The Lume Pad, Leia's game-changing, award-winning, and world's first Lightfield tablet, is an all-in-one Android 10-powered tablet that can run 3D Lightfield apps, games, photos, and videos. Depth, texture, and light bring content to life, making it more immersive and sensory. Leia combines nanotechnology and artificial intelligence to create the future of experiences.

Location

Company Stage

Age of Data

Experience

Industry

Company

Senior Director, Accounting

GitLab

$170k - $318k

$169,700 - $318,300

Fastly

$228k - $285k

$228,280 - $285,350

Vaxcyte

$241k - $268k

$241,000 - $268,000

Metropolis

$190k - $220k

$190,000 - $220,000

Artera (formerly WELL Health)

$143k - $198k

$143,000 - $198,000

Leia

$126k - $189k

$126,344 - $189,116